Osteopore Limited (ASX:OSX)

Market Cap	3.38M +18.8%
Revenue (ttm)	3.06M +10.7%
Net Income	-3.72M
EPS	-0.02
Shares Out	562.50M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,607,538
Average Volume	5,250,333
Open	0.0060
Previous Close	0.0060
Day's Range	0.0060 - 0.0070
52-Week Range	0.0060 - 0.0480
Beta	-0.07
RSI	41.37
Earnings Date	May 29, 2026

About Osteopore

Osteopore Limited, a regenerative medicine company, engages in the production of 3D-printed biomimetic and bioresorbable implants in Vietnam, South Korea, the Philippines, Singapore, India, Malaysia, the Netherlands, Thailand, Australia, and internationally. The company commercializes products designed to enable natural bone healing across multiple therapeutic areas. Its technology fabricates specific micro-structured scaffolds for bone regeneration through 3D printing and bioresorbable material. The company manufactures and trades medical impl...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2003
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: OSX

Financial Performance

In 2025, Osteopore's revenue was 3.06 million, an increase of 10.65% compared to the previous year's 2.76 million. Losses were -3.72 million, 11.0% more than in 2024.